Osteostatin-loaded onto mesoporous ceramics improves the early phase of bone regeneration in a rabbit osteopenia model

Acta Biomaterialia

Volumn 8, Issue 6, 2012, Pages 2317-2323

  Lozano, Daniel ^a,b   Trejo, Cynthia G ^c   Gómez Barrena, Enrique ^d   Manzano, Miguel ^e,f   Doadrio, Juan C ^e,f   Salinas, Antonio J ^e,f   Vallet Regí, María ^e,f   García Honduvilla, Natalio ^c   Esbrit, Pedro ^a,b   Buján, Julia ^c  

^a HOSPITAL UNIVERSITARIO FUNDACIÓN JIMÉNEZ DÍAZ   (Spain)

^b INSTITUTO DE SALUD CARLOS III   (Spain)

^c UNIVERSITY OF ALCALÁ   (Spain)

^d UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

^e UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

^f BIOMATERIALES Y NANOMEDICINA CIBER BBN   (Spain)

Author keywords

Bone regeneration; Osteoporosis; Osteostatin; SBA15 mesoporous silica

Indexed keywords

BIOCERAMICS; BONE; DISEASES; MESOPOROUS MATERIALS; REPAIR; SILICA;

BONE FORMATION; BONE REGENERATION; BONE REPAIR; MESOPOROUS CERAMICS; MESOPOROUS SILICAS; OSTEOPENIA; OSTEOPOROTIC; OSTEOSTATIN; PARATHYROID HORMONES; SBA15 MESOPOROUS SILICUM;

TISSUE REGENERATION;

BIOCERAMICS; CYCLINE; METHYLPREDNISOLONE; OSTEOPONTIN; OSTEOSTATIN; PARATHYROID HORMONE RELATED PROTEIN; TRANSCRIPTION FACTOR RUNX2; UNCLASSIFIED DRUG; VASCULOTROPIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE DEFECT; BONE DEVELOPMENT; BONE REGENERATION; BONE REMODELING; CONTROLLED STUDY; ENCAPSULATION; FEMALE; FEMUR; IMPLANT; INFLAMMATION; MATERIAL COATING; NONHUMAN; OSSIFICATION; OSTEOPENIA; OSTEOPOROSIS; POROSITY; PRIORITY JOURNAL; RABBIT; STAINING; TISSUE REGENERATION;

ANIMALIA; ORYCTOLAGUS CUNICULUS;

EID: 84860539712     PISSN: 17427061     EISSN: 18787568     Source Type: Journal    
DOI: 10.1016/j.actbio.2012.03.014     Document Type: Article

References (37)

1. A.X. Le, T. Miclau, D. Hu, and J.A. Helms Molecular aspects of healing in stabilized and non-stabilized fractures J Orthop Res 19 2001 78 84
2. F. Deschaseaux, L. Sensébé, and D. Heymann Mechanisms of bone repair and regeneration Trends Mol Med 15 2009 417 429
3. L.C. Gerstenfeld, D.M. Cullinane, G.L. Barnes, D.T. Graves, and T.A. Einhorn Fracture healing as a post-natal developmental process: molecular, spatial, and temporal aspects of its regulation J Cell Biochem 88 2003 873 884
4. L. Pederson, M. Ruan, J.J. Westendorf, S. Khosla, and M.J. Oursler Regulation of bone formation by osteoclasts involves Wnt/BMP signaling and the chemokine sphingosine-1-phosphate Proc Natl Acad Sci USA 105 2008 20764 20769
5. J. Caetano-Lopes, A. Lopes, A. Rodrigues, D. Fernandes, I.P. Perpétuo, and T. Monjardino Upregulation of inflammatory genes and downregulation of sclerostin gene expression are key elements in the early phase of fragility fracture healing PLoS One 6 2011 e16947
6. P. De Biase, and R. Capanna Clinical applications of BMPs Injury 36 Suppl. 3 2005 S43 S466
7. J.-B. Kim, P. Leucht, K. Lam, C. Luppen, D.T. Berge, and R. Nusse Bone regeneration is regulated by Wnt signaling J Bone Miner Res 22 2007 1913 1923
8. Z.S. Patel, S. Young, Y. Tabata, J.A. Cansen, M.E. Wong, and A.G. Mikos Dual delivery of an angiogenic and an osteogenic growth factor for bone regeneration in a critical size defect model Bone 43 2008 931 940
9. M.M. Deckers, R.L. van Bezooijen, G. van der Horst, J. Hoogendam, C. van der Bent, and Papapoulos Bone morphogenetic proteins stimulate angiogenesis through osteoblast-derived vascular endothelial growth factor A Endocrinology 143 2002 1545 1553
10. T. Kon, T.J. Cho, T. Aizawa, M. Yamazaki, N. Nooh, and D. Graves Expression of osteoprotegerin, receptor activator of NF-kappaB ligand (osteoprotegerin ligand) and related proinflammatory cytokines during fracture healing J Bone Miner Res 16 2001 1004 1014
11. R. Gruber, H. Koch, B.A. Doll, F. Tegtmeier, T.A. Einhorn, and J.O. Hollinger Fracture healing in the elderly patient Exp Gerontol 41 2006 1080 1093
12. P. Martínez, P. Esbrit, A. Rodrigo, M.V. Alvarez-Arroyo, and M.E. Martínez Age-related changes in parathyroid hormone-related protein and vascular endothelial growth factor in human osteoblastic cells Osteoporos Int 13 2002 874 881
13. H. Lu, D. Kraut, L.C. Gerstenfeld, and D.T. Graves Diabetes interferes with the bone formation by affecting the expression of transcription factors that regulate osteoblast differentiation Endocrinology 144 2003 346 352
14. D. Lozano, L.F. de Castro, S. Dapía, I. Andrade-Zapata, F. Manzarbeitia, and M.V. Alvarez-Arroyo Role of parathyroid hormone-related protein in the decreased osteoblast function in diabetes-related osteopenia Endocrinology 150 2009 2027 2035
15. S. Hough, L.V. Avioli, M.A. Bergfeld, M.D. Fallon, E. Slatopolsky, and S.L. Teitelbaum Correction of abnormal bone and mineral metabolism in chronic streptozotocin-induced diabetes mellitus in the rat by insulin therapy Endocrinology 108 1981 2228 2234
16. W.R. Walsh, P. Sherman, C.R. Howlett, D.H. Sonnabend, and M.G. Ehrlich Fracture healing in a rat osteopenia model Clin Orthop Relat Res 342 1997 218 227
17. T.T. Andreassen, C. Ejersted, and H. Oxlund Intermittent parathyroid hormona (1e34) treatment increases callus formation and mechanical strength of healing rat fractures J Bone Miner Res 14 1999 960 968
18. T. Shirota, M. Tashiro, K. Ohno, and A. Yamaguchi Effect of intermittent parathyroid hormone (1-34) treatment on the bone response after placement of titanium implants into the tibia of ovariectomized rats J Oral Maxillofac Surg 61 2003 471 480
19. M.P. Bostrom, S.C. Gamradt, P. Asnis, B.H. Vickery, E. Hill, and Z. Avnur Parathyroid hormone-related protein analog RS-66271 is an effective therapy for impaired bone healing in rabbits on corticosteroid therapy Bone 26 2000 437 442
20. L.F. de Castro, D. Lozano, S. Dapía, S. Portal-Nuñez, J.R. Caeiro, and E. Gomez-Barrena Role of the N- and C-terminal fragments of parathyroid hormone-related protein as putative therapies to improve bone regeneration under high glucocorticoid treatment Tissue Eng Part A 16 2010 1157 1168
21. D. Lozano, L. Fernández-de-Castro, S. Portal-Núñez, A. López-Herradón, S. Dapía, and E. Gómez-Barrena The C-terminal fragment of parathyroid hormone-related peptide promotes bone formation in diabetic mice with low turnover osteopenia Br J Pharmacol 162 2011 1424 1438
22. A.F. Stewart, R.L. Cain, D.B. Burr, D. Jacob, C.H. Turner, and J.M. Hock Six-month daily administration of parathyroid hormone and parathyroid hormone-related protein peptides to adult ovariectomized rats markedly enhances bone mass and biomechanical properties: a comparison of human parathyroid hormone 1-34, parathyroid hormone-related protein 1-36, and SDZ-parathyroid hormone 893 J Bone Miner Res 15 2000 1517 1525
23. 2+ through a receptor different from the type 1 PTH/PTHrP receptor in osteoblastic osteosarcoma UMR 106 cells Endocrinology 142 2001 2752 2759
24. 107](107-139) Biochim Biophys Acta 1432 1999 64 72
25. D. Lozano, M. Manzano, J.C. Doadrio, A.J. Salinas, M. Vallet-Regí, and E. Gómez-Barrena Osteostatin-loaded bioceramics stimulate osteoblastic growth and differentiation Acta Biomater 6 2010 797 803
26. C.G. Trejo, D. Lozano, M. Manzano, J.C. Doadrio, A.J. Salinas, and S. Dapía The osteoinductive properties of mesoporous silicate coated with osteostatin in a rabbit femur cavity defect model Biomaterials 31 2010 8564 8573
27. D. Zhao, Q. Hou, J. Fena, B.F. Chmelka, and G.D. Stucky Nonionic triblock and star diblock copolymer and oligomeric surfactant synthesis of highly ordered, hydrothermally stable, mesoporous silica structures J Am Chem Soc 120 1998 6024 6036
28. J.C. Doadrio, E.M.B. Sousa, I. Izquierdo-Barba, A.L. Doadrio, J. Pérez-Pariente, and M. Vallet-Regí Functionalization of mesoporous materials with long alkyl chains as a strategy for controlling drug delivery pattern J Mater Chem 16 2006 462 466
29. A.L. Doadrio, J.C. Doadrio, J.M. Sánchez-Montero, A.J. Salinas, and M. Vallet-Regí A rational explanation of the vancomycin release from SBA15 and its derivative by molecular modeling Micropor Mesopor Mater 132 2010 559 566
30. S. Castañeda, E. Calvo, R. Largo, R. González- González, C. de la Piedra, and M. Díaz-Curiel Characterization of a new experimental model of osteoporosis in rabbits J Bone Miner Metab 26 2008 53 59
31. S. Portal-Núñez, D. Lozano, L. Fernández de Castro, A.R. de Gortázar, X. Nogués, and P. Esbrit Alterations of the Wnt/β-catenin pathway and its target genes for the N- and C-terminal domains of parathyroid hormone-related protein in bone from diabetic mice FEBS Lett 584 2010 3095 3100
32. A.I. Alford, and K.D. Hankenson Matricellular proteins: extracellular modulators of bone development, remodeling, and regeneration Bone 38 2006 749 757
33. X. Li, M.S. Ominsky, Q.T. Niu, N. Sun, B. Daugherty, and D. DAgostin Targeted deletion of the sclerostin gene in mice results in increased bone formation and bone strength J Bone Miner Res 23 2008 860 891
34. L.F. de Castro, D. Lozano, S. Portal-Núñez, M. Maycas, M. De la Fuente, and J.R. Caeiro Comparison of the Skeletal effects induced by daily administration of PTHrP (1-36) and PTHrP (107-139) to ovariectomized mice J Cell Physiol 227 2012 1752 1760
35. V. Alonso, A.R. de Gortázar, J.A. Ardura, I. Andrade-Zapata, M.V. Álvarez-Arroyo, and P. Esbrit Parathyroid hormone-related protein (107-139) increases human osteoblastic cell survival by activation of vascular endothelial growth factor receptor-2 J Cell Physiol 217 2008 717 727
36. A.R. de Gortázar, V. Alonso, and M.V. Alvarez-Arroyo Esbrit. Transient exposure to PTHrP-107-139 exerts anabolic effects through vascular endothelial growth factor receptor 2 in human osteoblastic cells in vitro Calcif Tissue Int 79 2006 360 369
37. C.L. Duvall, W.R. Taylor, D. Weiss, A.M. Wojtowicz, and R.E. Guldberg Impaired angiogenesis, early callus formation, and late stage remodeling in fracture healing of osteopontin-deficient mice J Bone Miner Res 22 2007 286 297